Startseite UR
Publikationen von Heudobler, Daniel
(ORCID: 0000-0002-8790-4584)
 | Eine Stufe nach oben |
Anzahl der Einträge: 16.
2026
Harrer, Dennis Christoph 
, Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2026)
Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias.
Frontiers in Pharmacology 17.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Reichle, Albrecht und Heudobler, Daniel
(2026)
Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid.
International Journal of Molecular Sciences 27 (2), S. 1067.
Scheiter, Alexander , Mellin, Simon, Keil, Felix , Meier, Johannes, Heudobler, Daniel , Brummer, Christina, Einhell, Sabine , Zwicker, Benjamin, Wutzlhofer, Elena, Hierl, Frederik, Klemm, Sophie, Lüftl, Elena, Schneider, Tom, Perl, Markus, Klier-Richter, Margit, Immel, Alexander, Kaltofen, Till , Grube, Matthias, Bumes, Elisabeth , Seitz, Stephan, Schulz, Christian , Haferkamp, Sebastian , Drexler, Konstantin , Troeger, Anja, Steger, Felix, Schlosser-Hupf, Sophie, Tews, Hauke Christian, Kandulski, Arne , Wohlfart, Kristina, Erber, Ramona , Schönbuchner, Ines, Lessel, Davor , Schnabel, Marco J., Sedlmeier, Anja M. , Klinkhammer-Schalke, Monika, Maurer, Julia , Calvisi, Diego F. , Pukrop, Tobias , Kaiser, Ulrich , Hirsch, Daniela, Dietmaier, Wolfgang, Evert, Matthias, Lüke, Florian und Utpatel, Kirsten
(2026)
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients.
BMC Medicine 24 (1).
2025
Bernardi, Christine , Wolff, Daniel , Lüke, Florian , Hies, Johannes, Horn, Ruth, Seitz, Frederike, Heudobler, Daniel , Herr, Wolfgang und Herrmann, Anne
(2025)
How to improve informed consent processes in clinical trials with cancer patients: a qualitative analysis of multidisciplinary experts’ perspectives.
BMC Medical Ethics 26 (1).
Proescholdt, Martin A. , Araceli, Tommaso, Schebesch, Karl-Michael, Doenitz, Christian, Wendl, Christina, Evert, Katja , Noeva, Ekaterina, Hoehne, Julius, Riemenschneider, Markus J., Hirsch, Daniela , Schmidt, Nils Ole , Sparrer, Daniela, Lüke, Florian , Heudobler, Daniel , Pukrop, Tobias und Blazquez, Raquel
(2025)
MetInfilt: A prospective trial highlighting the importance of the histological growth pattern in brain metastases.
Translational Oncology 60, S. 102480.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2025)
MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck.
Frontiers in Pharmacology 16.
Boyer, Lisa, Bernardi, Christine, Leitzmann, Michael , Koller, Michael , Pukrop, Tobias , Einhell, Sabine, Heudobler, Daniel , Steindorf, Karen, Herr, Wolfgang und Herrmann, Anne
(2025)
Preliminary effectiveness of social prescription and virtual patient information in increasing tertiary prevention among cancer patients (ESPRIT): protocol for a single-centre, randomised controlled pilot trial.
BMJ Open 15 (1), e087177.
2024
Reuthner, Kathrin, Aubele, P., Menhart, Karin , Rath, Philipp, Harrer, D. C., Herr, Wolfgang, Hahn, Joachim, Vogelhuber, Martin, Heudobler, Daniel , Lueke, F., Reichle, Albrecht und Grube, Matthias
(2024)
Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin’s disease developing resistance to pembrolizumab.
Frontiers in Pharmacology 15.
Bernardi, Christine, Wolff, Daniel , Lüke, Florian , Hies, Johannes, Hallowell, Nina, Horn, Ruth, Seitz, Frederike, Heudobler, Daniel und Hermann-Johns, Anne
(2024)
“Uninformed consent” in clinical trials with cancer patients: A qualitative analysis of patients’ and support persons’ communication experiences and needs.
Patient Education and Counseling 122, S. 108144.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel
(2024)
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.
Frontiers in Oncology 13.
2023
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2023)
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.
Cancers 16 (1), S. 180.
2022
Lüke, Florian, Haller, Florian, Utpatel, Kirsten, Krebs, Markus, Meidenbauer, Norbert, Scheiter, Alexander , Spoerl, Silvia, Heudobler, Daniel , Sparrer, Daniela, Kaiser, Ulrich, Keil, Felix , Schubart, Christoph D., Tögel, Lars, Einhell, Sabine, Dietmaier, Wolfgang, Huss, Ralf, Dintner, Sebastian, Sommer, Sebastian, Jordan, Frank, Goebeler, Maria-Elisabeth, Metz, Michaela, Haake, Diana, Scheytt, Mithun, Gerhard-Hartmann, Elena, Maurus, Katja, Brändlein, Stephanie, Rosenwald, Andreas, Hartmann, Arndt, Märkl, Bruno, Einsele, Hermann , Mackensen, Andreas, Herr, Wolfgang, Kunzmann, Volker, Bargou, Ralf, Beckmann, Matthias W., Pukrop, Tobias , Trepel, Martin, Evert, Matthias, Claus, Rainer und Kerscher, Alexander Nikolaus
(2022)
Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium.
Cancers 14 (20), S. 5040.
Lüke, Florian , Harrer, Dennis Christoph, Pantziarka, Pan , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel
(2022)
Drug Repurposing by Tumor Tissue Editing.
Frontiers in Oncology 2022 (12), S. 900985.
Blazquez, Rachel, Proescholdt, Martin A. , Klauser, Marlene, Schebesch, Karl-Michael, Doenitz, Christian, Heudobler, Daniel , Stange, Lena, Riemenschneider, Markus J. , Bumes, Elisabeth , Rosengarth, Katharina, Schicho, Andreas , Schmidt, Nils Ole , Brawanski, Alexander, Pukrop, Tobias und Wendl, Christina
(2022)
Breakouts - a radiological sign of poor prognosis in patients with brain metastases.
Frontiers in Oncology.
2021
Lüke, Florian, Harrer, Dennis C., Menhart, Karin, Wolff, Daniel, Holler, Ernst, Hellwig, Dirk, Herr, Wolfgang, Grube, Matthias, Vogelhuber, Martin, Reichle, Albrecht und Heudobler, Daniel
(2021)
Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease.
Frontiers in Pharmacology 12 (599561), S. 1-8.
2020
Lüke, Florian , Orsó, Evelyn , Kirsten, Jana, Poeck, Hendrik, Grube, Matthias, Wolff, Daniel, Burkhardt, Ralph , Lunz, Dirk, Lubnow, Matthias, Schmidt, Barbara, Hitzenbichler, Florian, Hanses, Frank, Salzberger, Bernd , Evert, Matthias, Herr, Wolfgang, Brochhausen, Christoph, Pukrop, Tobias, Reichle, Albrecht und Heudobler, Daniel
(2020)
Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells.
eJHaem 1 (1), S. 376-383.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707